Unlocking the potential of Southeast Asia: Opportunities, challenges, and insights

Roundtable summary

Unlocking the potential of Southeast Asia: Opportunities, challenges, and insights

Tap into expert perspectives and strategic analysis on the key advantages and lingering challenges of basing pivotal and late-phase clinical trials in the Southeast Asia region. Access critical takeaways and expert commentary from a recent roundtable discussion at BIO Hong Kong, hosted by Citeline and featuring executive insights from Novotech.

Read the summary now for expert views on:

Leveraging Southeast Asia’s greatest strengths as a pivotal and late-phase trial destination
Evolving regulatory developments making the region more trial-friendly – but at uneven speeds
Expanding clinical trial activity in Southeast Asia via key infrastructure changes
Creating greater visibility into the types of research being conducted across Southeast Asia
Elevating the region’s appeal to trial sponsors through pivotal partnerships